Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Channel Nine Entertainment IPO and HPC Biosciences IPO.
Channel Nine Entertainment IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while HPC Biosciences IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Guiness Corporate Advisors Pvt Ltd | Guiness Corporate Advisors Pvt Ltd |
| Registrar | Beetal Financial & Computer Services (P) Limited | Cameo Corporate Services Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Channel Nine Entertainment IPO is up to ₹11.67 Cr whereas the issue size of the HPC Biosciences IPO is up to ₹15.75 Cr. The final issue price of Channel Nine Entertainment IPO is ₹25.00 per share and of HPC Biosciences IPO is ₹35.00 per share.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹25.00 per share | ₹35.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 46,68,000 shares | 45,00,000 shares |
| Issue Size Total (Amount) | up to ₹11.67 Cr | up to ₹15.75 Cr |
Channel Nine Entertainment IPO opens on Feb 22, 2013, while HPC Biosciences IPO opens on Mar 01, 2013. The closing date of Channel Nine Entertainment IPO and HPC Biosciences IPO is Feb 26, 2013, and Mar 05, 2013, respectively.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 22, 2013 | Mar 01, 2013 |
| Issue Close | Feb 26, 2013 | Mar 05, 2013 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Channel Nine Entertainment IPO P/E ratio is , as compared to HPC Biosciences IPO P/E ratio of .
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Channel Nine Entertainment IPO retail investors (RII) are offered while in HPC Biosciences IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Channel Nine Entertainment IPO and in HPC Biosciences IPO.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Channel Nine Entertainment IPO subscribed in total, whereas HPC Biosciences IPO subscribed .
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
